Eligibility for Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke

Publisher： Karger

E-ISSN： 1421-9786|22|5-6|423-428

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.22, Iss.5-6, 2006-11, pp. : 423-428

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Repeated Intravenous Treatment with Recombinant Tissue-Type Plasminogen Activator in Patients with Acute Ischemic Stroke

By  

European Neurology, Vol. 74, Iss. 3-4, 2015-09 ,pp. : 127-134

Karger

Access to resources Recommend Favorite

Low-Dose Tissue Plasminogen Activator and Standard-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke in Asian Populations: A Review

By  

Cerebrovascular Diseases, Vol. 36, Iss. 3, 2013-10 ,pp. : 161-166

Karger

Access to resources Recommend Favorite

Very Early versus Delayed Rehabilitation for Acute Ischemic Stroke Patients with Intravenous Recombinant Tissue Plasminogen Activator: A Nationwide Retrospective Cohort Study

By  

Cerebrovascular Diseases, Vol. 42, Iss. 1-2, 2016-03 ,pp. : 41-48

Karger

Access to resources Recommend Favorite

Vascular Aphasia Outcome after Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis for Ischemic Stroke

By  

European Neurology, Vol. 71, Iss. 5-6, 2014-02 ,pp. : 288-295

Karger

Access to resources Recommend Favorite

Frequency and Predictors of Symptomatic Intracerebral Hemorrhage in Patients with Ischemic Stroke Treated with Recombinant Tissue Plasminogen Activator outside Clinical Trials

By  

Cerebrovascular Diseases, Vol. 23, Iss. 2-3, 2006-11 ,pp. : 85-90

Karger

Access to resources Recommend Favorite